Researchers at Istanbul University Institute of Oncology have concluded that patients with high-risk extremity soft tissue sarcoma have similar 3-year outcomes whether they are assigned to neoadjuvant sequential chemoradiotherapy or radiation alone. The findings were published in Contemporary Oncology.
“At the end of the day, radiation therapy in the setting of limb-sparing resection demonstrates good local control with or without chemotherapy,” she said. “And each patient, as an individual, needs to be assessed as to the relevance of chemotherapy for their cancer as it is highly dependent on staging and histologic subtypes."
Kılıç L, Ekene M, Karabulut S, Ağaoğlu F, Darendeliler E. Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience. Contemp Oncol. 2017;21(1):60-65. doi:10.5114/wo.2017.66658.
... to read the full story